In our 13th episode, we discuss smoking cessation. We present the impressive benefits in hard outcomes when people stop smoking. We then go through the list of interventions, from brief advice to the pharmaceutical options of nicotine replacement, two anti-depressants (Buproprion or Nortiriptyline) and the newest agent, Varenicline. Dosing, cessation rates and adverse events are reviewed (for medications, not cigarettes: that dose is zero).
1) Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease
2) Listening empathetically and asking if they are ready to quit smoking
5) Varenicline for smoking cessation